The Changing Landscape of Drug Discovery: A Look into the Future
In 2006, a young journalist visited Pfizer to discuss the company's research and development (R&D) plans. This was a time when the pharmaceutical industry was facing a significant drop in productivity. During the 1990s, the Food and Drug Administration (FDA) approved 311 new medicines. However, in t